Declaration of medical writing assistance in international peer-reviewed publications

Medical researchers have an ethical and scientific obligation to publish, but between one third and two thirds of research may remain unpublished. A major reason for nonpublication is lack of time, which may lead researchers to seek medical writing assistance. Guidelines from journal editors and medical writers encourage authors to acknowledge medical writers. We quantified the proportion of articles from international, peer-reviewed, high-ranking journals that reported medical writing assistance

Mechanism for Coordinated RNA Packaging and Genome Replication by Rotavirus Polymerase VP1

Rotavirus RNA-dependent RNA polymerase, VP1, catalyzes RNA synthesis within a subviral particle. This activity depends on core shell protein VP2. A conserved sequence at the 3′ end of plusstrand RNA templates is important for polymerase association and genome replication. We have determined the structure of VP1 at 2.9 Å resolution, as apoenzyme and in complex with RNA. The cage-like enzyme is similar to reovirus λ3, with four tunnels leading to or from a central, catalytic cavity. A distinguishing characteristic of VP1 is specific recognition, by conserved features of the template-entry channel, of four bases, UGUG, in the conserved 3′ sequence. Well-defined interactions with these bases position the RNA so that its 3′ end overshoots the initiating register, producing a stable but catalytically inactive complex. We propose that specific 3′ end recognition selects rotavirus RNA for packaging and that VP2 activates the auto-inhibited VP1/RNA complex to coordinate packaging and genome replication.Molecular and Cellular Biolog

Advancing the Application of Design of Experiments (DOE) to Synthetic Theater Operations Research Model (STORM) Data

NPS NRP Project PosterThe Navy uses simulation-based campaign analysis to help measure risk for investment options for how best to equip, organize, supply, maintain, train, and employ our naval forces. The Synthetic Theater Operations Research Model (STORM) is a stochastic simulation model used to support campaign analysis by the U.S. Navy, Marine Corps, and Air Force. Building, testing, running, and analyzing campaign scenarios in STORM can be a complex, time-consuming process. The goal of this research is to apply Design Of Experiment (DOE) methods in the selection and creation of Design Points (DPs) to minimize the number of modeling runs required for meaningful comparisons. Another objective is to understand how best DOE methods can complement traditional baseline and excursion modeling. In addition to regular reviews, the research deliverables will include: (1) a final brief and/or technical report, in addition to student theses (if applicable); (2) all findings, methods, and data used in the study; and (3) appropriate conference or journal papers related to this research.N8 - Integration of Capabilities & ResourcesThis research is supported by funding from the Naval Postgraduate School, Naval Research Program (PE 0605853N/2098). https://nps.edu/nrpChief of Naval Operations (CNO)Approved for public release. Distribution is unlimited.

Advancing the Application of Design of Experiments (DOE) to Synthetic Theater Operations Research Model (STORM) Data

NPS NRP Technical ReportThe Navy uses simulation-based campaign analysis to help measure risk for investment options for how best to equip, organize, supply, maintain, train, and employ our naval forces. The Synthetic Theater Operations Research Model (STORM) is a stochastic simulation model used to support campaign analysis by the U.S. Navy, Marine Corps, and Air Force. Building, testing, running, and analyzing campaign scenarios in STORM can be a complex, time-consuming process. The goal of this research is to apply Design Of Experiment (DOE) methods in the selection and creation of Design Points (DPs) to minimize the number of modeling runs required for meaningful comparisons. Another objective is to understand how best DOE methods can complement traditional baseline and excursion modeling. In addition to regular reviews, the research deliverables will include: (1) a final brief and/or technical report, in addition to student theses (if applicable); (2) all findings, methods, and data used in the study; and (3) appropriate conference or journal papers related to this research.N8 - Integration of Capabilities & ResourcesThis research is supported by funding from the Naval Postgraduate School, Naval Research Program (PE 0605853N/2098). https://nps.edu/nrpChief of Naval Operations (CNO)Approved for public release. Distribution is unlimited.

Advancing the Application of Design of Experiments (DOE) to Synthetic Theater Operations Research Model (STORM) Data

NPS NRP Executive SummaryThe Navy uses simulation-based campaign analysis to help measure risk for investment options for how best to equip, organize, supply, maintain, train, and employ our naval forces. The Synthetic Theater Operations Research Model (STORM) is a stochastic simulation model used to support campaign analysis by the U.S. Navy, Marine Corps, and Air Force. Building, testing, running, and analyzing campaign scenarios in STORM can be a complex, time-consuming process. The goal of this research is to apply Design Of Experiment (DOE) methods in the selection and creation of Design Points (DPs) to minimize the number of modeling runs required for meaningful comparisons. Another objective is to understand how best DOE methods can complement traditional baseline and excursion modeling. In addition to regular reviews, the research deliverables will include: (1) a final brief and/or technical report, in addition to student theses (if applicable); (2) all findings, methods, and data used in the study; and (3) appropriate conference or journal papers related to this research.N8 - Integration of Capabilities & ResourcesThis research is supported by funding from the Naval Postgraduate School, Naval Research Program (PE 0605853N/2098). https://nps.edu/nrpChief of Naval Operations (CNO)Approved for public release. Distribution is unlimited.

Using contractual incentives in district nursing in the English NHS: results from a qualitative study

© 2018 The author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. Since 2008, health policy in England has been focusing increasingly on improving quality in healthcare services. To ensure quality improvements in community nursing, providers are required to meet several quality targets, including an incentive scheme known as Commissioning for Quality and Innovation (CQUIN). This paper reports on a study of how financial incentives are used in district nursing, an area of care which is particularly difficult to measure and monitor

Understanding Shape and Centroid Deviations in 39 Strong Lensing Galaxy Clusters in Various Dynamical States

Through observational tests of strong lensing galaxy clusters, we can test simulation derived structure predictions that follow from $\Lambda$ Cold Dark Matter ($\Lambda$CDM) cosmology. The shape and centroid deviations between the total matter distribution, stellar matter distributions, and hot intracluster gas distribution serve as an observational test of these theoretical structure predictions. We measure the position angles, ellipticities, and locations/centroids of the brightest cluster galaxy (BCG), intracluster light (ICL), the hot intracluster medium (ICM), and the core lensing mass for a sample of strong lensing galaxy clusters from the SDSS Giant Arcs Survey (SGAS). We utilize HST WFC3/IR imaging data to measure the shapes/centroids of the ICL and BCG distributions and use Chandra ACIS-I X-ray data to measure the shapes/centroids of ICM. Additionally, we measure the concentration parameter c and asymmetry parameter A to incorporate cluster dynamical state into our analysis. Using this multicomponent approach, we attempt to constrain the astrophysics of our strong lensing cluster sample and evaluate the different components in terms of their ability to trace out the DM halo of clusters in various dynamical states.Comment: 6 pages, 4 figures, to appear in Proc. of the mm Universe 2023 conference, Grenoble (France), June 2023, published by F. Mayet et al. (Eds), EPJ Web of conferences, EDP Science

Functional analysis of drug resistance-associated mutations in the Trypanosoma brucei Adenosine Transporter 1 (TbAT1) and the proposal of a structural model for the protein

The Trypanosoma brucei aminopurine transporter P2/TbAT1 has long been implicated in the transport of, and resistance to, the diamidine and melaminophenyl arsenical classes of drugs that form the backbone of the pharmacopoeia against African trypanosomiasis. Genetic alterations including deletions and single nucleotide polymorphisms (SNPs) have been observed in numerous strains and clinical isolates. Here, we systematically investigate each reported mutation and assess their effects on transporter function after expression in a tbat1 -/- T. brucei line. Out of a set of six reported SNPs from a reported ‘resistance allele’, none significantly impaired sensitivity to pentamidine, diminazene or melarsoprol, relative to the TbAT1-WT allele, although several combinations, and the deletion of the codon for residue F316, resulted in highly significant impairment. These combinations of SNPs, and ΔF316, also strongly impaired the uptake of [3H]-adenosine and [3H]-diminazene, identical to the tbat1-/- control. The TbAT1 protein model predicted that residues F19, D140 and F316 interact with the substrate of the transporter. Mutation of D140 to alanine resulted in an inactive transporter, whereas the mutation F19A produced a transporter with a slightly increased affinity for [3H]-diminazene, but reduced the uptake rate. The results presented here validate earlier hypotheses of drug binding motifs for TbAT1

Health-related quality of Life in SCALOP, a randomized phase 2 trial comparing chemoradiation therapy regimens in locally advanced pancreatic cancer

PurposeChemoradiation therapy (CRT) for patients with locally advanced pancreatic cancer (LAPC) provides survival benefits but may result in considerable toxicity. Health-related quality of life (HRQL) measurements during CRT have not been widely reported. This paper reports HRQL data from the Selective Chemoradiation in Advanced Localised Pancreatic Cancer (SCALOP) trial, including validation of the QLQ-PAN26 tool in CRT.Methods and MaterialsPatients with locally advanced, inoperable, nonmetastatic carcinoma of the pancreas were eligible. Following 12 weeks of induction gemcitabine plus capecitabine (GEMCAP) chemotherapy, patients with stable and responding disease were randomized to a further cycle of GEMCAP followed by capecitabine- or gemcitabine-based CRT. HRQL was assessed with the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) and the EORTC Pancreatic Cancer module (PAN26).ResultsA total of 114 patients from 28 UK centers were registered and 74 patients randomized. There was improvement in the majority of HRQL scales during induction chemotherapy. Patients with significant deterioration in fatigue, appetite loss, and gastrointestinal symptoms during CRT recovered within 3 weeks following CRT. Differences in changes in HRQL scores between trial arms rarely reached statistical significance; however, where they did, they favored capecitabine therapy. PAN26 scales had good internal consistency and were able to distinguish between subgroups of patients experiencing toxicity.ConclusionsAlthough there is deterioration in HRQL following CRT, this resolves within 3 weeks. HRQL data support the use of capecitabine- over gemcitabine-based chemoradiation. The QLQ-PAN26 is a reliable and valid tool for use in patients receiving CRT

A pragmatic group sequential placebo controlled randomised trial to determine the effectiveness of Glyceryl trinitrate for retained placenta (GOT-IT): a study protocol

A retained placenta is diagnosed when the placenta is not delivered following delivery of the baby. It is a major cause of postpartum haemorrhage and treated by the operative procedure of manual removal of placenta (MROP).The aim of this pragmatic, randomised, placebo-controlled, double-blind UK-wide trial, with an internal pilot and nested qualitative research to adjust strategies to refine delivery of the main trial, is to determine whether sublingual glyceryl trinitrate (GTN) is (or is not) clinically and cost-effective for (medical) management of retained placenta. The primary clinical outcome is need for MROP, defined as the placenta remaining undelivered 15 min poststudy treatment and/or being required within 15 min of treatment due to safety concerns. The primary safety outcome is measured blood loss between administration of treatment and transfer to the postnatal ward or other clinical area. The primary patient-sided outcome is satisfaction with treatment and a side effect profile. The primary economic outcome is net incremental costs (or cost savings) to the National Health Service of using GTN versus standard practice. Secondary outcomes are being measured over a range of clinical and economic domains. The primary outcomes will be analysed using linear models appropriate to the distribution of each outcome. Health service costs will be compared with multiple trial outcomes in a cost-consequence analysis of GTN versus standard practice.Ethical approval has been obtained from the North-East Newcastle and North Tyneside 2 Research Ethics Committee (13/NE/0339). Dissemination plans for the trial include the Health Technology Assessment Monograph, presentation at international scientific meetings and publication in high-impact, peer-reviewed journals.ISCRTN88609453; Pre-results